BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1313251)

  • 1. Cyclic AMP turnover in intact tissue. Role of cyclic nucleotide phosphodiesterases.
    Barber R; Goka TJ; Butcher RW
    Adv Second Messenger Phosphoprotein Res; 1992; 25():1-11. PubMed ID: 1313251
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic nucleotides and phosphodiesterases in platelets.
    Haslam RJ; Dickinson NT; Jang EK
    Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic-3',5'-nucleotide phosphodiesterases in the cyclic adenosine monophosphate (cAMP)-mediated actions of vasopressin.
    Dousa TP
    Semin Nephrol; 1994 Jul; 14(4):333-40. PubMed ID: 7938948
    [No Abstract]   [Full Text] [Related]  

  • 4. Adaptation in cyclic AMP signalling processes: a central role for cyclic AMP phosphodiesterases.
    Houslay MD
    Semin Cell Dev Biol; 1998 Apr; 9(2):161-7. PubMed ID: 9599411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
    Rybalkin SD; Bornfeldt KE
    Thromb Haemost; 1999 Aug; 82(2):424-34. PubMed ID: 10605733
    [No Abstract]   [Full Text] [Related]  

  • 6. PDE4: arrested at the border.
    Brunton LL
    Sci STKE; 2003 Oct; 2003(204):PE44. PubMed ID: 14560046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors.
    Castro A; Jerez MJ; Gil C; Martinez A
    Med Res Rev; 2005 Mar; 25(2):229-44. PubMed ID: 15514991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics. Two genes link two distinct psychoses.
    Sawa A; Snyder SH
    Science; 2005 Nov; 310(5751):1128-9. PubMed ID: 16293746
    [No Abstract]   [Full Text] [Related]  

  • 9. Dynamic regulation of cAMP signaling by cGMP in the cardiovascular system: roles of phosphodiesterase 2 and phosphodiesterase 3 enzymes.
    Maurice DH
    Proc West Pharmacol Soc; 2003; 46():32-6. PubMed ID: 14699879
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the yeast low-Km cAMP-phosphodiesterase gene to control cyclic AMP levels in mammalian cells.
    Kessin RH; Fleischmann RD; Gottesman MM; Jastorff B; Van Lookeren Campagne MM
    Adv Second Messenger Phosphoprotein Res; 1992; 25():13-27. PubMed ID: 1313255
    [No Abstract]   [Full Text] [Related]  

  • 11. Real-time monitoring of phosphodiesterase inhibition in intact cells.
    Herget S; Lohse MJ; Nikolaev VO
    Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases.
    Manganiello VC
    J Mol Cell Cardiol; 1987 Oct; 19(10):1037-40. PubMed ID: 2830403
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of high affinity cAMP phosphodiesterase activities in the response of S49 cells to agonists.
    Barber R; Goka TJ; Butcher RW
    Mol Pharmacol; 1987 Dec; 32(6):753-9. PubMed ID: 2826989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME; Garrett RL; Thompson WJ; Strada SJ
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain.
    Torres-López JE; Argüelles CF; Granados-Soto V
    Proc West Pharmacol Soc; 2002; 45():141-3. PubMed ID: 12434560
    [No Abstract]   [Full Text] [Related]  

  • 16. Defective cAMP metabolism and defective memory in Drosophila.
    Dudai Y; Buxbaum J; Corfas G; Orgad S; Segal D; Sher B; Uzzan A; Zvi S
    Acta Biochim Biophys Hung; 1986; 21(3):177-92. PubMed ID: 3026127
    [No Abstract]   [Full Text] [Related]  

  • 17. Type 4 phosphodiesterase-dependent pathways: role in inflammatory processes.
    Jacob C; Martin-Chouly C; Lagente V
    Therapie; 2002; 57(2):163-8. PubMed ID: 12185965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for activation of the rat adipocyte particulate cyclic-GMP-inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin.
    Manganiello VC; Degerman E; Smith CJ; Vasta V; Tornqvist H; Belfrage P
    Adv Second Messenger Phosphoprotein Res; 1992; 25():147-64. PubMed ID: 1313257
    [No Abstract]   [Full Text] [Related]  

  • 19. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
    Ashby B
    Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiology of the renin-producing juxtaglomerular cells.
    Friis UG; Jensen BL; Jørgensen F; Andreasen D; Skøtt O
    Nephrol Dial Transplant; 2005 Jul; 20(7):1287-90. PubMed ID: 15967788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.